Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl G Maki

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|October 27, 2006
P53 gene alterations identified in classical Hodgkin's lymphoma cell linesCarl G Maki
Aging|July 7, 2010
Decision-making by p53 and mTORCarl G Maki
Current Pharmaceutical Design|March 12, 2011
Pharmacologic activation of p53 by small-molecule MDM2 antagonistsHong Shen, Carl G Maki
Journal of Cellular Biochemistry|August 31, 2010
p53 and p21(Waf1) are recruited to distinct PML-containing nuclear foci in irradiated and Nutlin-3a-treated U2OS cellsHong Shen, Carl G Maki
Translational Cancer Research|October 3, 2017
The IGF-1R/AKT pathway determines cell fate in response to p53Lei Duan, Carl G Maki
Translational Lung Cancer Research|March 18, 2024
Determinants of Aurora kinase B inhibitor sensitivity in small cell lung cancerLei Duan, Carl G Maki
The Journal of Biological Chemistry|May 22, 2010
Persistent p21 expression after Nutlin-3a removal is associated with senescence-like arrest in 4N cellsHong Shen, Carl G Maki
Cell Signaling|January 13, 2025
Potential biomarkers for MCL1 inhibitor sensitivityLei Duan, Carl G Maki
Molecular Cancer Therapeutics|April 8, 2010
Nutlin-3a induces cytoskeletal rearrangement and inhibits the migration and invasion capacity of p53 wild-type cancer cellsDiarmuid M Moran, Carl G Maki
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2003
Stability and ubiquitination of the tumor suppressor protein p53Lesley J Jardine, Carl G Maki
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|October 27, 2006
P53 gene alterations identified in classical Hodgkin's lymphoma cell linesCarl G Maki
Aging|July 7, 2010
Decision-making by p53 and mTORCarl G Maki
Current Pharmaceutical Design|March 12, 2011
Pharmacologic activation of p53 by small-molecule MDM2 antagonistsHong Shen, Carl G Maki
Journal of Cellular Biochemistry|August 31, 2010
p53 and p21(Waf1) are recruited to distinct PML-containing nuclear foci in irradiated and Nutlin-3a-treated U2OS cellsHong Shen, Carl G Maki
Translational Cancer Research|October 3, 2017
The IGF-1R/AKT pathway determines cell fate in response to p53Lei Duan, Carl G Maki
Translational Lung Cancer Research|March 18, 2024
Determinants of Aurora kinase B inhibitor sensitivity in small cell lung cancerLei Duan, Carl G Maki
The Journal of Biological Chemistry|May 22, 2010
Persistent p21 expression after Nutlin-3a removal is associated with senescence-like arrest in 4N cellsHong Shen, Carl G Maki
Cell Signaling|January 13, 2025
Potential biomarkers for MCL1 inhibitor sensitivityLei Duan, Carl G Maki
Molecular Cancer Therapeutics|April 8, 2010
Nutlin-3a induces cytoskeletal rearrangement and inhibits the migration and invasion capacity of p53 wild-type cancer cellsDiarmuid M Moran, Carl G Maki
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2003
Stability and ubiquitination of the tumor suppressor protein p53Lesley J Jardine, Carl G Maki
Pageof 6